The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

M.D. Anderson Cancer Center

Status: Active, not recruiting

Conditions: Cancer

Treatments: Behavioral: Cannabidiol (CBD); Behavioral: Cannabis (Marijuana)

Study type: Observational

Funder types: Other

Identifiers

NCT05836857

2022-0049

NCI-2023-03440 (Other Identifier)

Details and patient eligibility

About

To collect information about how patients in the pain management clinic use cannabis/CBD, including how often it is used, why it is used (for example, to manage pain or other symptoms), and where patients get their information on cannabis/CBD for pain management

Full description

Objectives

Primary Objective:

The primary objective of this study is to investigate the prevalence of current and prior cannabis and/or CBD use in cancer patients who present to the pain management clinic at MDACC.

Secondary Objectives:

The secondary objective is to investigate the reason for cannabis/CBD use (e.g. pain, neuropsychiatric symptoms, recreational or other use), degree of symptom improvement with use, frequency of use, methods of use (e.g. inhaled vs. ingested), sources of information on cannabis/CBD, and patient interest in learning more from their physicians about cannabis/CBD for cancer pain.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18 years or older
2. Cancer patients who present to the MD Anderson Pain Medicine Clinic as a new patient or consult
3. Willing to give informed consent
4. Willing to complete the survey

Exclusion criteria

1. Refusal of informed consent
2. Refusal to complete the survey
3. Patients who previously completed the survey
4. Patients who opt-out or change their mind after agreeing to participate
5. Already an established patient at MDACC Pain Medicine Clinic
6. Patients scheduled to see Dr Abdi (PI).

Trial design

100 participants in 1 patient group

Cannabis (Marijuana) and Cannabidiol (CBD)

Description:

This is a survey to determine the number of cancer pain patients who use and/or used Marijuana and/or CBD for pain or other symptom burdens.

Treatment:

Behavioral: Cannabis (Marijuana)

Behavioral: Cannabidiol (CBD)